Nausheen Ahmed

Health Care Foundation of Greater Kansas City

Also affiliated with University of Kansas Medical Center, Cellular Therapeutics (United Kingdom)

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Optimizing the post-CAR T monitoring period in recipients of axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel”.

Optimizing the post-CAR T monitoring period in recipients of axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel

Blood Advances(2024)10.1182/bloodadvances.2023012549

N/A

0.533DataRank · unranked

34 citations

William Wesson, Forat Lutfi, David L. Porter, Veronika Bachanová, Loretta J. Nastoupil +11 more

CD19-directed CART therapy for T-cell/histiocyte–rich large B-cell lymphoma

Blood Advances(2024)10.1182/bloodadvances.2024013863

N/A

0.464DataRank · unranked

21 citations

Joshua Fein, Kwang Woo Ahn, Molly Allbee-Johnson, Nausheen Ahmed, Farrukh T. Awan +14 more

The Glass Wall: Gendered Authorship Disparities in CD 19 and BCMA CAR-T Clinical Trials for Lymphoma and Myeloma

Clinical Lymphoma Myeloma & Leukemia(2024)10.1016/j.clml.2024.05.022

N/A

0DataRank · unranked

3 citations

William Wesson, Emerson Logan, Carine Tabak, Muhammad Umair Mushtaq, Tara L. Lin +7 more

Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis

UNC Libraries(2024)10.17615/d5s2-9s76

N/A

0DataRank · unranked

0 citations

Peter A. Riedell, R. Alejandro Sica, Tania Jain, Brian T. Hill, Craig S. Sauter +24 more

CRS or ICANS Are Rare Beyond 2 Weeks After Lisocabtagene Maraleucel Infusion: Data From Clinical Trials and the Real-World Setting

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.10.024

N/A

0DataRank · unranked

3 citations

Matthew A. Lunning, Mazyar Shadman, Sairah Ahmed, Jeremy S. Abramson, Miguel‐Angel Perales +14 more

Assessing cognitive function in transplantation and chimeric antigen receptor t cell therapy recipients: Expert recommendations from the survivorship, aging and biobehavioral special interest groups of the American Society for Transplantation and Cellular Therapy

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.06.026

N/A

0DataRank · unranked

2 citations

Nausheen Ahmed, Andrew Artz, Neel S. Bhatt, Rachel Custatis, Manuel Espinoza‐Gutarra +24 more

Siltuximab for chimeric antigen receptor T-cell therapy–related CRS and ICANS: a multicenter retrospective analysis

Blood Advances(2024)10.1182/bloodadvances.2024013688

N/A

0DataRank · unranked

40 citations

Qiuhong Zhao, Marcus Geer, Chenyu Lin, James Westholder, Joeseph Maakaron +12 more

Real-world outcomes of axicabtagene ciloleucel (axi-cel) for the treatment of relapsed/refractory (R/R) secondary central nervous system lymphoma (SCNSL).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.7024

N/A

0DataRank · unranked

0 citations

Babatunde Adedokun, Hamza Hashmi, Mazyar Shadman, Allison Winter, Alex F. Herrera +14 more

Lisocabtagene maraleucel for relapsed/refractory large B-cell lymphoma: a cell therapy consortium real-world analysis

Blood Advances(2024)10.1182/bloodadvances.2024014164

N/A

0DataRank · unranked

24 citations

Connor B. Grady, Loretta J. Nastoupil, Alejandro Luna, Nausheen Ahmed, Richard T. Maziarz +12 more